On Invalid Date, Passage Bio (NASDAQ: PASG) reported Q4 2023 earnings per share (EPS) of -$0.30, up 38.78% year over year. Total Passage Bio earnings for the quarter were -$16.76 million. In the same quarter last year, Passage Bio's earnings per share (EPS) was -$0.49.
As of Q1 2024, Passage Bio's earnings has grown year over year. Passage Bio's earnings in the past year totalled -$102.06 million.
What is PASG's earnings date?
Passage Bio's earnings date is Invalid Date. Add PASG to your watchlist to be reminded of PASG's next earnings announcement.
What was PASG's revenue last quarter?
On Invalid Date, Passage Bio (NASDAQ: PASG) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Passage Bio's revenue was $0.00.
What was PASG's revenue growth in the past year?
As of Q1 2024, Passage Bio's revenue has grown null year over year. Passage Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.